WMT

94.32

-0.59%↓

COST

969.9

-0.05%↓

TGT

104.25

-0.52%↓

KR

70.46

-0.34%↓

STZ

172.24

+0.05%↑

WMT

94.32

-0.59%↓

COST

969.9

-0.05%↓

TGT

104.25

-0.52%↓

KR

70.46

-0.34%↓

STZ

172.24

+0.05%↑

WMT

94.32

-0.59%↓

COST

969.9

-0.05%↓

TGT

104.25

-0.52%↓

KR

70.46

-0.34%↓

STZ

172.24

+0.05%↑

WMT

94.32

-0.59%↓

COST

969.9

-0.05%↓

TGT

104.25

-0.52%↓

KR

70.46

-0.34%↓

STZ

172.24

+0.05%↑

WMT

94.32

-0.59%↓

COST

969.9

-0.05%↓

TGT

104.25

-0.52%↓

KR

70.46

-0.34%↓

STZ

172.24

+0.05%↑

Search

USANA Health Sciences Inc

Suletud

32.84 -1.71

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

32.52

Max

33.31

Põhinäitajad

By Trading Economics

Sissetulek

4.8M

9.3M

Müük

36M

250M

P/E

Sektori keskmine

17.654

27.852

Aktsiakasum

0.73

Kasumimarginaal

3.723

Töötajad

1,700

EBITDA

11M

27M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+1.77% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

22. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

91M

610M

Eelmine avamishind

34.55

Eelmine sulgemishind

32.84

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

USANA Health Sciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. juuli 2025, 22:19 UTC

Omandamised, ülevõtmised, äriostud

FCC Approves U.S. Cellular Sale to T-Mobile

11. juuli 2025, 17:28 UTC

Suurimad hinnamuutused turgudel

SharpLink Gaming Gains on Ethereum Purchase

11. juuli 2025, 16:57 UTC

Tulu

BASF Cuts Outlook on Global Economy Uncertainty

11. juuli 2025, 21:45 UTC

Market Talk

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11. juuli 2025, 19:46 UTC

Omandamised, ülevõtmised, äriostud

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11. juuli 2025, 19:45 UTC

Market Talk

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11. juuli 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11. juuli 2025, 18:18 UTC

Market Talk

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11. juuli 2025, 17:35 UTC

Market Talk

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11. juuli 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11. juuli 2025, 16:53 UTC

Market Talk

Crude Futures Add to Early Gains -- Market Talk

11. juuli 2025, 16:42 UTC

Tulu

BASF Cuts Outlook on Global Economic Uncertainty

11. juuli 2025, 16:08 UTC

Market Talk

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11. juuli 2025, 16:05 UTC

Tulu

BASF Will Publish Half-Year Results on July 30

11. juuli 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

11. juuli 2025, 16:04 UTC

Market Talk

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11. juuli 2025, 16:03 UTC

Tulu

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11. juuli 2025, 16:02 UTC

Tulu

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11. juuli 2025, 16:01 UTC

Tulu

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11. juuli 2025, 16:00 UTC

Tulu

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11. juuli 2025, 15:59 UTC

Tulu

BASF Cuts 2025 Earnings View

11. juuli 2025, 15:58 UTC

Tulu

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11. juuli 2025, 15:57 UTC

Tulu

BASF 2Q EBIT Before Special Items EUR810M

11. juuli 2025, 15:54 UTC

Tulu

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11. juuli 2025, 15:54 UTC

Tulu

BASF 2Q Sales Fell 2.1% on Year

11. juuli 2025, 15:53 UTC

Tulu

BASF 2Q Sales EUR15.77B

11. juuli 2025, 15:52 UTC

Tulu

BASF: This Was in Line With Consensus Estimates

11. juuli 2025, 15:52 UTC

Tulu

BASF 2Q Ebitda Before Special Items EUR1.77B

11. juuli 2025, 15:49 UTC

Tulu

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11. juuli 2025, 15:41 UTC

Market Talk

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Võrdlus sarnastega

Hinnamuutus

USANA Health Sciences Inc Prognoos

Hinnasiht

By TipRanks

1.77% tõus

12 kuu keskmine prognoos

Keskmine 34 USD  1.77%

Kõrge 34 USD

Madal 34 USD

Põhineb 1 Wall Streeti analüütiku instrumendi USANA Health Sciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

28.405 / 29.84Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

No Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.